Fagron NV (FAGR.BR) Income Statement Analysis

See more : JC Finance&Tax Interconnect Holdings Ltd. (002530.SZ) Income Statement Analysis – Financial Results

Complete financial analysis of Fagron NV (FAGR.BR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fagron NV, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.

You may be interested

Fagron NV (FAGR.BR)

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Website: https://www.fagron.com

About Fagron NV

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue	762.99M	683.88M	573.81M	555.97M	534.70M	471.68M	436.93M	421.84M	473.00M	447.06M	386.12M	547.02M	492.33M	424.06M	391.32M	354.51M	304.37M	276.97M	283.25M	283.28M
Cost of Revenue	606.94M	397.72M	326.31M	309.24M	294.68M	263.40M	247.58M	237.41M	253.12M	234.91M	215.03M	358.75M	326.13M	0.00	0.00	0.00	0.00	186.09M	194.02M	198.71M
Gross Profit	156.05M	286.17M	247.50M	246.73M	240.02M	208.28M	189.36M	184.43M	219.87M	212.15M	171.09M	188.27M	166.20M	424.06M	391.32M	354.51M	304.37M	90.88M	89.22M	84.58M
Gross Profit Ratio	20.45%	41.84%	43.13%	44.38%	44.89%	44.16%	43.34%	43.72%	46.49%	47.45%	44.31%	34.42%	33.76%	100.00%	100.00%	100.00%	100.00%	32.81%	31.50%	29.86%
Research & Development	2.70M	2.30M	2.17M	2.05M	1.35M	1.19M	1.24M	960.00K	1.14M	4.33M	6.91M	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
General & Administrative	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	285.42M	267.43M	0.00	0.00	0.00	0.00	0.00
Selling & Marketing	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SG&A	0.00	49.99M	33.77M	31.40M	30.82M	30.11M	2.39M	96.80M	103.84M	101.64M	71.17M	0.00	0.00	285.42M	267.43M	0.00	0.00	0.00	0.00	0.00
Other Expenses	47.91M	185.00M	157.57M	154.35M	152.55M	131.74M	112.99M	110.16M	140.06M	115.60M	97.94M	130.19M	119.94M	-182.80M	93.35M	324.47M	277.93M	64.79M	60.78M	56.26M
Operating Expenses	50.61M	185.00M	157.57M	154.35M	152.55M	131.74M	112.99M	110.16M	140.06M	115.60M	97.94M	130.19M	119.94M	102.62M	360.77M	324.47M	277.93M	64.79M	60.78M	56.26M
Cost & Expenses	654.36M	582.72M	483.89M	463.59M	447.23M	395.14M	360.56M	347.57M	393.19M	350.51M	312.97M	488.94M	446.07M	102.62M	360.77M	324.47M	277.93M	250.87M	254.81M	254.96M
Interest Income	5.32M	4.06M	1.42M	753.00K	1.45M	643.00K	2.44M	11.71M	1.15M	19.94M	1.17M	1.14M	1.27M	477.00K	554.00K	506.00K	1.60M	739.00K	-55.00K	283.00K
Interest Expense	22.98M	10.62M	8.01M	10.85M	12.20M	11.17M	17.12M	29.71M	24.76M	20.67M	15.36M	12.30M	10.45M	6.44M	7.99M	12.55M	8.60M	5.50M	3.52M	5.08M
Depreciation & Amortization	34.52M	31.30M	26.48M	27.48M	25.96M	16.24M	15.09M	18.18M	21.12M	16.34M	14.25M	17.04M	14.53M	12.67M	11.98M	9.27M	7.45M	6.11M	5.25M	5.19M
EBITDA	134.12M	135.62M	116.00M	115.50M	111.71M	87.17M	92.39M	49.52M	42.33M	110.17M	72.00M	65.64M	59.64M	49.17M	43.08M	39.81M	37.27M	26.97M	33.21M	30.91M
EBITDA Ratio	17.58%	18.74%	19.59%	20.84%	20.84%	18.12%	20.42%	11.44%	-30.81%	24.49%	20.76%	13.31%	12.60%	11.59%	11.01%	11.23%	12.12%	11.63%	11.73%	11.78%
Operating Income	105.44M	97.91M	87.44M	88.74M	84.39M	73.47M	74.61M	17.88M	-150.34M	94.34M	73.91M	58.06M	46.26M	36.02M	30.54M	30.03M	26.44M	20.12M	23.81M	25.87M
Operating Income Ratio	13.82%	14.32%	15.24%	15.96%	15.78%	15.58%	17.08%	4.24%	-31.78%	21.10%	19.14%	10.61%	9.40%	8.49%	7.80%	8.47%	8.69%	7.26%	8.40%	9.13%
Total Other Income/Expenses	-21.00M	-10.14M	-10.62M	-15.02M	-14.22M	-18.64M	-19.91M	-24.25M	-224.17M	-24.01M	-16.95M	-10.39M	-9.18M	-5.96M	-7.44M	-12.05M	-7.00M	-5.51M	-4.00M	-5.23M
Income Before Tax	84.45M	87.77M	76.82M	73.72M	69.89M	54.84M	55.97M	-6.36M	-195.33M	69.85M	52.58M	43.14M	37.08M	30.06M	23.11M	17.99M	19.44M	14.61M	19.81M	20.64M
Income Before Tax Ratio	11.07%	12.83%	13.39%	13.26%	13.07%	11.63%	12.81%	-1.51%	-41.30%	15.62%	13.62%	7.89%	7.53%	7.09%	5.90%	5.07%	6.39%	5.28%	6.99%	7.29%
Income Tax Expense	13.40M	17.70M	15.44M	13.68M	14.20M	11.55M	8.92M	11.75M	6.95M	26.66M	8.80M	-685.00K	8.94M	7.58M	3.47M	-3.09M	3.18M	2.49M	4.74M	6.85M
Net Income	70.55M	69.61M	61.00M	59.60M	55.69M	42.49M	46.66M	-20.56M	-202.33M	16.23M	-32.10M	43.91M	28.14M	22.48M	19.64M	14.90M	16.26M	12.12M	15.06M	13.80M
Net Income Ratio	9.25%	10.18%	10.63%	10.72%	10.41%	9.01%	10.68%	-4.87%	-42.78%	3.63%	-8.31%	8.03%	5.72%	5.30%	5.02%	4.20%	5.34%	4.38%	5.32%	4.87%
EPS	0.97	0.96	0.84	0.83	0.78	0.59	0.65	-0.38	-6.01	0.49	-0.97	1.33	0.87	0.69	0.60	0.44	0.56	0.44	0.56	0.51
EPS Diluted	0.97	0.96	0.84	0.82	0.76	0.59	0.65	-0.38	-5.98	0.48	-0.95	1.33	0.85	0.69	0.60	0.44	0.56	0.44	0.56	0.51
Weighted Avg Shares Out	73.00M	72.87M	72.64M	72.09M	71.80M	71.74M	71.74M	53.96M	33.69M	33.22M	33.10M	32.96M	32.49M	32.40M	32.63M	33.14M	28.67M	27.00M	27.00M	27.00M
Weighted Avg Shares Out (Dil)	73.00M	72.89M	72.72M	72.39M	73.01M	71.97M	71.88M	53.96M	33.82M	33.61M	33.63M	33.56M	32.88M	32.51M	32.63M	33.14M	28.67M	27.00M	27.00M	27.00M

No news found for: FAGR.BR

Source: https://incomestatements.info
Category: Stock Reports

Fagron NV (FAGR.BR) Income Statement Analysis – Financial Results

Leave a Reply Cancel reply

Recent Posts

Categories